Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionextracellular matrix structural constituent

MUC2 MUC3A MUC5AC MUC6

2.64e-05188194GO:0005201
GeneOntologyMolecularFunctionlaminin binding

LYPD3 SSC5D

4.73e-0434192GO:0043236
GeneOntologyMolecularFunctionextracellular matrix binding

LYPD3 SSC5D

2.17e-0373192GO:0050840
GeneOntologyCellularComponentGolgi lumen

MUC2 MUC16 MUC3A MUC5AC MUC6

3.86e-08109195GO:0005796
GeneOntologyCellularComponentmucus layer

MUC2 MUC5AC

2.35e-063192GO:0070701
GeneOntologyCellularComponentextracellular matrix

MUC2 MUC5AC MUC6 SSC5D

2.56e-03656194GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

MUC2 MUC5AC MUC6 SSC5D

2.59e-03658194GO:0030312
DomainTIL

MUC2 MUC5AC MUC6

1.95e-0712193PF01826
DomainC8

MUC2 MUC5AC MUC6

1.95e-0712193PF08742
DomainC8

MUC2 MUC5AC MUC6

2.54e-0713193SM00832
DomainUnchr_dom_Cys-rich

MUC2 MUC5AC MUC6

2.54e-0713193IPR014853
DomainTIL_dom

MUC2 MUC5AC MUC6

3.23e-0714193IPR002919
DomainVWFD

MUC2 MUC5AC MUC6

4.96e-0716193PS51233
DomainVWD

MUC2 MUC5AC MUC6

4.96e-0716193SM00216
DomainVWF_type-D

MUC2 MUC5AC MUC6

4.96e-0716193IPR001846
DomainVWD

MUC2 MUC5AC MUC6

4.96e-0716193PF00094
DomainVWC_out

MUC2 MUC5AC MUC6

8.56e-0719193SM00215
DomainCT

MUC2 MUC5AC MUC6

1.36e-0622193SM00041
DomainCys_knot_C

MUC2 MUC5AC MUC6

2.02e-0625193IPR006207
DomainCTCK_2

MUC2 MUC5AC MUC6

2.02e-0625193PS01225
DomainVWF_dom

MUC2 MUC5AC MUC6

9.99e-0642193IPR001007
DomainWxxW_domain

MUC2 MUC5AC

1.47e-056192IPR025155
DomainMucin2_WxxW

MUC2 MUC5AC

1.47e-056192PF13330
DomainSEA

MUC16 MUC3A

8.86e-0514192SM00200
DomainCTCK_1

MUC2 MUC5AC

1.49e-0418192PS01185
DomainSEA_dom

MUC16 MUC3A

2.45e-0423192IPR000082
DomainSEA

MUC16 MUC3A

2.45e-0423192PS50024
DomainVWFC_1

MUC2 MUC5AC

6.05e-0436192PS01208
DomainVWC

MUC2 MUC5AC

6.74e-0438192SM00214
DomainVWFC_2

MUC2 MUC5AC

6.74e-0438192PS50184
DomainPH

DGKK AGAP2

2.23e-02229192PF00169
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC16 MUC3A MUC5AC MUC6

7.86e-1016134M27410
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC16 MUC3A MUC5AC MUC6

1.03e-0917134M27412
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC2 MUC16 MUC5AC MUC6

2.58e-0921134MM15706
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC3A MUC5AC MUC6

3.81e-0923134M556
PathwayREACTOME_DECTIN_2_FAMILY

MUC16 MUC3A MUC5AC MUC6

6.43e-0926134M27483
PathwayREACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS

MUC2 MUC16 MUC5AC MUC6

2.06e-0760134MM15636
PathwayREACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS

MUC16 MUC3A MUC5AC MUC6

2.35e-0762134M546
PathwayREACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS

MUC16 MUC3A MUC5AC MUC6

3.43e-0768134M27303
PathwayREACTOME_O_LINKED_GLYCOSYLATION

MUC2 MUC16 MUC5AC MUC6

2.29e-06109134MM15164
PathwayREACTOME_O_LINKED_GLYCOSYLATION

MUC16 MUC3A MUC5AC MUC6

2.46e-06111134M27416
PathwayREACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS

MUC16 MUC3A MUC5AC MUC6

6.22e-06140134M27484
PathwayREACTOME_DISEASES_OF_GLYCOSYLATION

MUC16 MUC3A MUC5AC MUC6

6.76e-06143134M27275
PathwayREACTOME_DISEASES_OF_METABOLISM

MUC16 MUC3A MUC5AC MUC6

6.09e-05250134M27554
PathwayREACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION

MBD5 LYPD3 MUC2 MUC16 MUC5AC MUC6 NFRKB

8.93e-051389137MM15307
PathwayREACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION

MBD5 LYPD3 MUC16 MUC3A MUC5AC MUC6 NFRKB

1.31e-041475137M19806
PathwayREACTOME_UCH_PROTEINASES

MBD5 NFRKB

2.81e-0387132MM15287
PathwayREACTOME_UCH_PROTEINASES

MBD5 NFRKB

3.84e-03102132M27576
Pubmed

Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.

MUC2 MUC16 MUC3A MUC5AC MUC6

3.12e-131820518834073
Pubmed

Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.

MUC2 MUC16 MUC5AC MUC6

1.19e-12620419110483
Pubmed

Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.

MUC2 MUC5AC MUC6

1.63e-10320318300795
Pubmed

Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

MUC2 MUC5AC MUC6

1.63e-10320318825309
Pubmed

Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).

MUC2 MUC5AC MUC6

6.50e-10420336367122
Pubmed

Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.

MUC2 MUC5AC MUC6

6.50e-10420317471237
Pubmed

The mouse secreted gel-forming mucin gene cluster.

MUC2 MUC5AC MUC6

6.50e-10420314984930
Pubmed

Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.

MUC2 MUC5AC MUC6

6.50e-10420317401217
Pubmed

Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.

MUC2 MUC5AC MUC6

6.50e-10420333154304
Pubmed

Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.

MUC2 MUC5AC MUC6

6.50e-10420312676567
Pubmed

Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.

MUC2 MUC5AC MUC6

6.50e-10420323807779
Pubmed

Gastric mucin expression in first-degree relatives of gastric cancer patients.

MUC2 MUC5AC MUC6

6.50e-10420324901817
Pubmed

Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.

MUC2 MUC5AC MUC6

6.50e-10420329869461
Pubmed

Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.

MUC2 MUC5AC MUC6

6.50e-10420325298197
Pubmed

Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?

MUC2 MUC5AC MUC6

6.50e-10420320929551
Pubmed

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.

MUC2 MUC5AC MUC6

6.50e-10420327298226
Pubmed

Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?

MUC2 MUC5AC MUC6

1.62e-09520322261707
Pubmed

MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.

MUC2 MUC5AC MUC6

1.62e-09520316475027
Pubmed

Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins.

MUC2 MUC5AC MUC6

3.25e-09620317982272
Pubmed

Intestinal MUC2 and gastric M1/MUC5AC in preneoplastic lesions induced by 1,2-dimethylhydrazine in rat: a sequential analysis.

MUC2 MUC5AC

3.14e-07220217203232
Pubmed

Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins.

MUC2 MUC5AC

3.14e-07220223832517
Pubmed

Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.

MUC2 MUC5AC

3.14e-07220223832516
Pubmed

Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.

MUC2 MUC5AC

3.14e-07220220731025
Pubmed

Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.

MUC5AC MUC6

3.14e-07220228321513
Pubmed

Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs.

MUC5AC MUC6

3.14e-0722029422745
Pubmed

Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.

MUC5AC MUC6

3.14e-07220211988092
Pubmed

The complete genomic organization of the human MUC6 and MUC2 mucin genes.

MUC2 MUC6

3.14e-07220215081123
Pubmed

High-fat Diet Alters the Glycosylation Patterns of Duodenal Mucins in a Murine Model.

MUC2 MUC6

3.14e-07220232141795
Pubmed

Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.

MUC16 MUC5AC

3.14e-07220218782111
Pubmed

MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis.

MUC2 MUC6

3.14e-07220220878553
Pubmed

Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma.

MUC2 MUC5AC

3.14e-07220214594655
Pubmed

Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.

MUC16 MUC5AC

3.14e-07220222220206
Pubmed

In vivo glycosylation of mucin tandem repeats.

MUC2 MUC5AC

3.14e-07220211445551
Pubmed

Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.

MUC2 MUC5AC

3.14e-07220212527922
Pubmed

The central exons of the human MUC2 and MUC6 mucins are highly repetitive and variable in sequence between individuals.

MUC2 MUC6

3.14e-07220230504806
Pubmed

Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.

MUC5AC MUC6

3.14e-07220212360467
Pubmed

Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.

MUC16 MUC5AC

3.14e-07220224722639
Pubmed

Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide.

MUC2 MUC5AC

3.14e-07220212820724
Pubmed

Mucolytic activity of bacterial and human chitinases.

MUC2 MUC5AC

3.14e-07220217321686
Pubmed

Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.

MUC2 MUC5AC MUC6

3.71e-072520334391772
Pubmed

Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.

MUC3A MUC5AC

9.42e-07320218163520
Pubmed

Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.

MUC16 MUC5AC

9.42e-07320233232357
Pubmed

Differences in the expression of mucins in various forms of cystitis glandularis.

MUC2 MUC5AC

9.42e-07320217659847
Pubmed

Genetic variation in MUC1, MUC2 and MUC6 genes and evolution of gastric cancer precursor lesions in a long-term follow-up in a high-risk area in Spain.

MUC2 MUC6

9.42e-07320222402132
Pubmed

Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression.

MUC2 MUC6

9.42e-07320223305535
Pubmed

Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.

MUC5AC MUC6

9.42e-07320223828549
Pubmed

Clinicopathological and prognostic significance of MUC-2, MUC-4 and MUC-5AC expression in japanese gastric carcinomas.

MUC2 MUC5AC

9.42e-07320223464473
Pubmed

A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.

MUC5AC MUC6

9.42e-07320219924550
Pubmed

Meconium ileus in cystic fibrosis is not linked to central repetitive region length variation in MUC1, MUC2, and MUC5AC.

MUC2 MUC5AC

9.42e-07320224920497
Pubmed

Gene expression profiling of colorectal mucinous adenocarcinomas.

MUC2 MUC5AC

9.42e-07320220485009
Pubmed

Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast.

MUC2 MUC5AC

9.42e-07320217333267
Pubmed

Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.

MUC2 MUC6

9.42e-07320216447040
Pubmed

Mucin gene polymorphisms in otitis media patients.

MUC2 MUC5AC

9.42e-07320219718741
Pubmed

Mucin expression in reactive gastropathy: an immunohistochemical analysis.

MUC5AC MUC6

9.42e-07320217227128
Pubmed

Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.

MUC2 MUC6

1.88e-06420221596555
Pubmed

Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.

MUC2 MUC5AC

1.88e-06420225638393
Pubmed

PGE(2) induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activation.

MUC2 MUC5AC

1.88e-06420223619266
Pubmed

Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.

MUC2 MUC5AC

1.88e-06420222269464
Pubmed

Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.

MUC2 MUC5AC

1.88e-06420222691042
Pubmed

Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.

MUC5AC MUC6

1.88e-06420224603585
Pubmed

Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells.

MUC2 MUC5AC

1.88e-06420212391274
Pubmed

[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].

MUC2 MUC5AC

1.88e-06420217991319
Pubmed

Polymorphism of human mucin genes in chest disease: possible significance of MUC2.

MUC2 MUC5AC

3.14e-06520211062147
Pubmed

Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.

MUC2 MUC6

3.14e-06520224840470
Pubmed

Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12.

MUC2 MUC5AC

3.14e-06520212135769
Pubmed

pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins.

MUC2 MUC5AC

3.14e-06520210611155
Pubmed

Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.

MUC2 MUC5AC

3.14e-06520212507512
Pubmed

Differential expression of MUC genes in endometrial and cervical tissues and tumors.

MUC2 MUC5AC

3.14e-06520216188033
Pubmed

Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum.

MUC2 MUC5AC

4.71e-06620216142311
Pubmed

Conditional stabilization of beta-catenin expands the pool of lung stem cells.

MUC2 MUC5AC

2.44e-051320218356571
Pubmed

Loss of Pancreas upon Activated Wnt Signaling Is Concomitant with Emergence of Gastrointestinal Identity.

MUC2 MUC5AC

1.96e-043620227736991
Pubmed

Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2.

MUC2 MUC5AC

2.54e-044120222675208
Cytoband11p15.5

MUC2 MUC5AC MUC6

1.83e-0511820311p15.5
CytobandEnsembl 112 genes in cytogenetic band chr11p15

MUC2 MUC5AC MUC6

1.80e-03564203chr11p15
CytobandEnsembl 112 genes in cytogenetic band chr6q25

FNDC1 CNKSR3

2.31e-03164202chr6q25
GeneFamilyCD molecules|Mucins

MUC2 MUC16 MUC3A MUC5AC MUC6

7.76e-1221175648
CoexpressionNABA_ECM_AFFILIATED

MUC2 MUC16 MUC3A MUC5AC MUC6

1.55e-07170205M5880
CoexpressionNABA_ECM_AFFILIATED

MUC2 MUC16 MUC5AC MUC6

5.71e-06158204MM17063
CoexpressionSCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN

CAVIN2 AFF3

2.48e-0510202M1355
CoexpressionSCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN

CAVIN2 AFF3

2.48e-0510202MM566
CoexpressionDESCARTES_FETAL_STOMACH_GOBLET_CELLS

MUC5AC MUC6

6.60e-0516202M40303
CoexpressionNABA_MATRISOME

MUC2 MUC16 MUC3A MUC5AC MUC6 FNDC1

8.57e-051026206M5889
CoexpressionNABA_MATRISOME_ASSOCIATED

MUC2 MUC16 MUC3A MUC5AC MUC6

2.07e-04751205M5885
CoexpressionTAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP

PALLD CAVIN2 CNKSR3

2.19e-04156203M17275
CoexpressionNABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS

MUC16 FNDC1

2.38e-0430202M47990
CoexpressionLIU_CDX2_TARGETS_UP

MUC2 MUC6

3.24e-0435202M16637
CoexpressionMARTENS_TRETINOIN_RESPONSE_UP

MUC2 MUC16 FOXN1 MUC6 AGAP2

3.76e-04855205M2098
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL

SSC5D FNDC1 CAVIN2

3.84e-04189203M45678
CoexpressionGSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP

MBD5 RIPOR1 NFRKB

4.47e-04199203M7984
CoexpressionGSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP

MUC2 MUC5AC AGAP2

4.47e-04199203M7710
CoexpressionGSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP

LYPD3 CNKSR3 AFF3

4.53e-04200203M8258
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN

MUC16 RIPOR1 CAVIN2 AFF3

4.64e-04491204MM455
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MUC2 SSC5D PALLD AFF3

7.50e-071622045f009b231f21861afee9cc0c569082e1135f929c
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MUC2 SSC5D PALLD AFF3

7.50e-07162204b936f8040dcd4db621ccded19237af8df7d0ed6e
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9

MUC2 MUC6 CNKSR3

3.23e-0514020382b150e9e9962460a5cd6bef7ee04f28f5c05d1a
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LYPD3 FNDC1 NFRKB

3.74e-05147203f5109e0f4e8b46a977a763c9c72a2df9840e3977
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LYPD3 FNDC1 NFRKB

3.74e-05147203ad0c575bc9c5f201f2a7810452e8b3f741e65d89
ToppCell343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

SSC5D IQCN NFRKB

3.97e-05150203744050a1b665c6989f37141348af3df7579a73c9
ToppCellnormal-na-Lymphocytic_B-B_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

MUC16 CAVIN2 AFF3

4.99e-05162203ae292318d339305932457bb0e91430594f7a3dfa
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

SSC5D PALLD FNDC1

5.18e-05164203e3983f655cdba308fb192182829f17bef99ce0ba
ToppCellControl|World / group, cell type (main and fine annotations)

MUC5AC IQCN AFF3

5.56e-05168203a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SSC5D PALLD AFF3

5.56e-05168203d19a115365c5415e51c039718d7669de788fcf33
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

SSC5D PALLD FNDC1

6.50e-05177203b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9

SSC5D PALLD FNDC1

6.61e-05178203142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SSC5D PALLD FNDC1

6.61e-051782038ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SSC5D PALLD FNDC1

6.61e-051782036c91331196696e0cf239d105f458e3230659fa38
ToppCellnucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC3A MUC5AC

6.72e-05179203859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

6.72e-0517920302c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCellnucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC3A MUC5AC

6.83e-051802033dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCellnucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC3A MUC5AC

6.83e-05180203668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.17e-051832037eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCellControl-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations)

MUC16 MUC3A MUC5AC

7.17e-0518320315d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.17e-0518320312daaea821e49bc94a01e2496331e92a80d27339
ToppCellAT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

FNDC1 CAVIN2 IQCN

7.17e-051832036821dca076318115d360ff426eb1218cfe104063
ToppCell343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

PALLD FNDC1 CAVIN2

7.29e-05184203c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCellControl-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations)

MUC16 MUC3A MUC5AC

7.29e-05184203d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5AC MUC6

7.29e-0518420301c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

PALLD FNDC1 CAVIN2

7.29e-051842031ed558a88215b248431c524ea16f13d9022ae98c
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.41e-051852033b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.41e-05185203e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.53e-051862036add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

PALLD CNKSR3 AFF3

7.77e-051882036d249fe92d51a19da19ec14bb2262d394255d577
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SSC5D PALLD FNDC1

7.77e-05188203c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.77e-051882033177b2c1723268d330d3e9f24f9e24492ace6286
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.77e-05188203293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SSC5D PALLD FNDC1

7.89e-05189203eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SSC5D PALLD FNDC1

7.89e-0518920340764f461b8aa1d3a2c5a30590b7fb9307d47d09
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.89e-051892037ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

7.89e-0518920345e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.02e-0519020370c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCellMesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor

SSC5D PALLD FNDC1

8.02e-05190203645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5AC MUC6

8.02e-051902033c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5AC MUC6

8.02e-0519020323f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCellLPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RIPOR1 CAVIN2 AFF3

8.02e-05190203106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.14e-0519120339092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.14e-05191203107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

8.14e-0519120314057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.14e-05191203bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

8.14e-05191203b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SSC5D PALLD AFF3

8.14e-051912031caf726bd07fdca389e678fc16304a6ef1790423
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SSC5D FNDC1 AFF3

8.14e-051912031b26056df078674f37a6c06f6256b30cfcec21a7
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SSC5D PALLD AFF3

8.14e-051912033d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.14e-05191203ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCellNS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MUC16 MUC5AC CAVIN2

8.27e-0519220302b11233b4da2d85b96498b3c6e22e3a31b3d049
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SSC5D FNDC1 AFF3

8.27e-05192203b35f0e422070ba9c7c1d9ff3eace4edc10286cde
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SSC5D PALLD FNDC1

8.27e-05192203992d08092edbc68c47b945deb8708379738c239a
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SSC5D PALLD FNDC1

8.40e-05193203dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SSC5D PALLD FNDC1

8.40e-05193203e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SSC5D PALLD FNDC1

8.53e-051942038fae8061b350336299aa81f378e07deadbd55123
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SSC5D PALLD FNDC1

8.53e-051942034d7d24390fdb379f943ddcc70a63f23955e10163
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.53e-05194203ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.66e-05195203dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCellNS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MUC16 MUC5AC CAVIN2

8.66e-05195203b0d782eeee30c797b4da9b3be29b864983fd9e71
ToppCellwk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

SSC5D PALLD FNDC1

8.66e-051952034dba732c8d8ecf0ed9ece1814dc4060402199ed9
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.66e-0519520349c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MUC3A MUC5AC MUC6

8.66e-0519520323ab7e2a419377c05bab0e92a2457afbcd3d9e07
ToppCellFibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4)

SSC5D PALLD FNDC1

8.66e-05195203a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.79e-05196203802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCellFibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

PALLD FNDC1 AFF3

8.79e-0519620324d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PALLD FNDC1 AFF3

8.79e-05196203fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SSC5D PALLD FNDC1

8.92e-0519720316758f181ef07c60aee63072e1da9572c5c85414
ToppCelldistal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MUC2 MUC16 MUC5AC

8.92e-05197203da1ed7303cc9cb2d205c0e5c49c52544d3540951
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5AC PALLD

8.92e-051972035c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SSC5D PALLD FNDC1

8.92e-051972039d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0
ToppCellmoderate-Lymphoid-NKT|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MUC2 MUC16 MUC5AC

8.92e-05197203003950f6ed32df64014845f9ec56179512a6cecc
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SSC5D PALLD FNDC1

8.92e-051972034cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SSC5D PALLD FNDC1

8.92e-05197203090a251194da3e2806989d9a522588f83f52da7f
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SSC5D PALLD FNDC1

8.92e-0519720343b5f8e917506c1717f9311584901b506ffd2c79
ToppCelldistal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MUC2 MUC16 MUC5AC

8.92e-05197203a00784ccfb1de6a96b91e2a8a2889b69f31a33da
ToppCelldistal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MUC2 MUC16 MUC5AC

8.92e-051972033fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SSC5D PALLD FNDC1

9.06e-05198203b258f672529fb2c03e62e2696d335043c4963280
ToppCellFibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

SSC5D PALLD FNDC1

9.06e-051982034f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCellwk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

SSC5D PALLD FNDC1

9.06e-05198203637f11e292b90d86cdc0d0d828eb26f38289c25b
ToppCell(5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

SSC5D PALLD FNDC1

9.06e-05198203196257c4420ac801ed9fbb444f11718adb7560ae
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MUC16 MUC3A CAVIN2

9.06e-051982035cfd1c030c0940136a397b5a4b5d6ecbaecf72eb
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LYPD3 MUC16 FOXN1

9.06e-05198203de5987588b9fa9ee8c595ba06d7d844ead0e3c74
ToppCellwk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

SSC5D PALLD FNDC1

9.06e-051982032d0c14f8cabab99bc6d7c27685437c78841c7245
ToppCellASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

RIPOR1 CAVIN2 CNKSR3

9.06e-05198203e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCellcellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SSC5D PALLD FNDC1

9.06e-05198203e9f434bfd072e590fe44d518057ee5aa653038f3
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MUC16 MUC3A CAVIN2

9.06e-0519820335edf6d5bedc2181fbdd56f43e458bc39f4eca16
ToppCellNS-moderate-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MUC2 MUC16 MUC5AC

9.06e-05198203361f3062f73a0add16dd6fbe927698416515879f
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MUC16 MUC3A CAVIN2

9.06e-05198203ff6d9455ebfe965cc6f48197172c0ebd3bddde81
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MUC16 MUC3A CAVIN2

9.06e-051982035375a2895cf995f0db4a61861093f01794707901
ToppCellBL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MUC2 MUC16 MUC5AC

9.06e-05198203484d16aaa601a1e11b871b0475dd01a2de1a29ce
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5AC PALLD

9.06e-05198203d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCelldistal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MUC16 SSC5D FNDC1

9.19e-051992038dd5b411d2f1626830b77a1616cc3fb67dc59338
ToppCelldistal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SSC5D PALLD FNDC1

9.19e-051992031f20addc0d138fec02ed6ca4c518169c568de263
ToppCellTracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 MUC5AC AFF3

9.19e-05199203f37114cf849837fdb8ed9a767de773e8681b7df3
ToppCellwk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

SSC5D PALLD FNDC1

9.19e-05199203a207b4891881149d4c50721310690fd794157723
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

SSC5D PALLD FNDC1

9.19e-051992036b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

SSC5D PALLD FNDC1

9.19e-05199203e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCelldistal-Epithelial-Differentiating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

LYPD3 MUC2 FOXN1

9.19e-05199203286d52f25120293620bdbfd62b832f08e118adf6
DrugRitodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; PC3; HT_HG-U133A

LYPD3 MUC5AC AGAP2 NFRKB

1.62e-051792044619_UP
Drug4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid

MUC2 MUC5AC

2.05e-058202ctd:C064545
DrugClemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A

MUC2 MUC5AC AGAP2 NFRKB

2.32e-051962042301_UP
DrugPractolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A

MUC2 MUC16 AGAP2 AFF3

2.41e-051982044603_UP
Drug4-hydroxyretinoic acid

MUC2 MUC5AC

4.81e-0512202ctd:C019429
DrugOvalbumin

MUC2 MUC5AC FNDC1

4.91e-0582203ctd:D010047
Diseasecholangiocarcinoma (is_marker_for)

MUC2 MUC16 MUC3A MUC5AC MUC6

6.19e-1064205DOID:4947 (is_marker_for)
Diseasemucinous adenocarcinoma (is_marker_for)

MUC2 MUC5AC MUC6

2.66e-095203DOID:3030 (is_marker_for)
Diseasecystitis (is_marker_for)

MUC2 MUC5AC

4.36e-072202DOID:1679 (is_marker_for)
Diseasepancreatic cancer (is_marker_for)

MUC16 MUC5AC MUC6 PALLD

6.01e-07101204DOID:1793 (is_marker_for)
Diseasekeratoconjunctivitis (is_marker_for)

MUC16 MUC5AC

1.31e-063202DOID:9368 (is_marker_for)
Diseasesputum mucin-5B amount

MUC2 MUC5AC

1.31e-063202OBA_2050332
Diseasepancreatic ductal carcinoma (is_marker_for)

MUC3A MUC5AC PALLD

9.35e-0661203DOID:3587 (is_marker_for)
Diseasebringing up phlegm, sputum or mucus on most days, self-reported

MUC2 MUC5AC

1.57e-059202EFO_0009824
Diseasedry eye syndrome (is_marker_for)

MUC16 MUC5AC

1.96e-0510202DOID:10140 (is_marker_for)
DiseaseInhalant adrenergic use measurement

MUC2 MUC16 MUC5AC

3.65e-0596203EFO_0009941
Diseasegastric ulcer (implicated_via_orthology)

MUC5AC MUC6

3.95e-0514202DOID:10808 (implicated_via_orthology)
Diseaseasthma

MUC2 MUC16 MUC5AC CNKSR3 AFF3

1.19e-04751205MONDO_0004979
DiseaseSjogren's syndrome (is_marker_for)

MUC16 MUC5AC

1.19e-0424202DOID:12894 (is_marker_for)
Diseasepneumonia

MUC2 MUC5AC

4.63e-0447202EFO_0003106
Diseasecystic fibrosis (is_marker_for)

MUC2 MUC5AC

8.05e-0462202DOID:1485 (is_marker_for)
Diseasepolychlorinated biphenyls measurement

MBD5 PALLD

8.85e-0465202EFO_0007042
Diseaseblood cobalt measurement

MUC16 POM121L12

2.12e-03101202EFO_0007577
Diseaseadult onset asthma

MUC2 MUC5AC

2.87e-03118202EFO_1002011
DiseaseAstigmatism

CNKSR3 AFF3

3.42e-03129202HP_0000483
Diseaserespiratory system disease

MUC2 MUC5AC

4.30e-03145202EFO_0000684
Diseaseosteoarthritis, knee

CAVIN2 CNKSR3

5.08e-03158202EFO_0004616
Diseasealcohol dependence

MUC2 MUC5AC

6.75e-03183202MONDO_0007079

Protein segments in the cluster

PeptideGeneStartEntry
TPSPMSPNPSPASSV

AFF3

1116

P51826
ATTPMPSPSPSPSSL

AGAP2

771

Q99490
ASTMTTTPPKTSPVP

IQCN

356

Q9H0B3
SPAMTSPSPVSSTSP

MUC16

5341

Q8WXI7
SPSMTSPSPVSSTSP

MUC16

5636

Q8WXI7
PNPTSTGTPPMTVTT

MUC6

1716

Q6W4X9
SPSPSPSPSPRTPMS

DGKK

196

Q5KSL6
SDSSMPPTPVTPVTP

NFRKB

711

Q6P4R8
SPPMTTPITPPASTT

MUC2

1501

Q02817
TTTPSPPTTTMTTPS

MUC2

1686

Q02817
PPTTTMTTPSPTTTP

MUC2

1691

Q02817
MTTPSPTTTPSSPIT

MUC2

1696

Q02817
TTTTPSSTTTPSPPP

MUC2

1711

Q02817
SSTTTPSPPPTTMTT

MUC2

1716

Q02817
TTMTTPSPTTTPSPP

MUC2

1726

Q02817
PSPTTTPSPPTTTMT

MUC2

1731

Q02817
TPSPPTTTMTTLPPT

MUC2

1736

Q02817
EMTSTAPPSTPTAPT

MUC2

4246

Q02817
SPPPVSSSITPTNTM

MUC3A

1006

Q02505
SPPPVPATSTSSMST

MUC5AC

1541

P98088
APMSRSPSTPQTTPS

POM121L12

31

Q8N7R1
TSTTKPMPAPTSQTP

LYPD3

266

O95274
TPASSPSSSSLPSPM

PALLD

751

Q8WX93
PSSSSLPSPMSPTPR

PALLD

756

Q8WX93
PPTTTMQPTTTTTPL

FNDC1

1446

Q4ZHG4
TIGSPRPSMPSSPST

MBD5

496

Q9P267
EKPSSPSPMPSSTPS

CAVIN2

21

O95810
LVTSSPTSSSMPPPQ

FOXN1

561

O15353
SPSPHPTTTPDPTMA

SSC5D

1146

A1L4H1
TTTPHPTMTPDPTTT

SSC5D

1296

A1L4H1
PTMTPDPTTTPYPTT

SSC5D

1301

A1L4H1
TSPPPATTQSPESTM

CNK3/IPCEF1

316

G9CGD6
TSPPPATTQSPESTM

CNKSR3

316

Q6P9H4
KTSMSPPTTTSPTPS

RIPOR1

636

Q6ZS17